Report overview
This report contains market size and forecasts of Clinical Stage Biotechnology in Global, including the following market information:
Global Clinical Stage Biotechnology Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Stage Biotechnology market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Phase I Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Clinical Stage Biotechnology include Minoryx, Inhibrx, NovaBiotics, RadioMedix, Artax Biopharma, Ribon Therapeutics, Brickell Biotech, Coave Therapeutics and Edesa Biotech, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clinical Stage Biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Stage Biotechnology Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Clinical Stage Biotechnology Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Global Clinical Stage Biotechnology Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Clinical Stage Biotechnology Market Segment Percentages, by Application, 2022 (%)
Bio-pharmaceuticals
Scientific Research
Global Clinical Stage Biotechnology Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Clinical Stage Biotechnology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Stage Biotechnology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Stage Biotechnology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Minoryx
Inhibrx
NovaBiotics
RadioMedix
Artax Biopharma
Ribon Therapeutics
Brickell Biotech
Coave Therapeutics
Edesa Biotech
CellCentric
LimmaTech Biologics AG
Adaptive Phage Therapeutics
Intra-ImmuSG
